Non-target screening using chromatography coupled to high-resolution mass spectrometry is a powerful tool in environmental ...

The nonsteroidal mineralocorticoid receptor antagonist finerenone has been reported to improve kidney and cardiovascular outcomes in persons with type 2 diabetes and chronic kidney disease (CKD).

Good morning, and welcome to Ocugen's Fourth Quarter and Full Year 2025 Financial Results and Business Update [Operator Instructions] I will now turn the call over to Tiffany Hamilton, Ocugen's Head ...

A large UK Biobank study of more than 350,000 adults found that social isolation, but not loneliness alone, was associated ...

India has endured a perplexing year in its diplomacy. After decades of growing closer to Washington, New Delhi saw its strategic calculus scrambled by the pressure tactics of the Trump administration, ...

Background Psoriatic disease has a complex effect on bone metabolism, resulting in both pathological bone formation and bone ...

An ongoing Phase III trial aims to further evaluate the drug's clinical efficacy in reducing seizures and affecting behavior ...

Share Market Highlights - Find here all the highlights related to Sensex, Nifty, BSE, NSE, share prices and Indian stock ...

Takeda Pharmaceutical Company Limited ( TAK) TD Cowen 46th Annual Health Care Conference March 2, 2026 1:10 PM EST ...

Stacey McKenna, Resident Senior Fellow, Integrated Harm Reduction, R Street Institute Testimony in Support of Senate Bill 398 ...

Smithsonian researcher Sarah Johnson studies bison specimens to understand how the species’s genetic diversity changed after ...